Patent Assignment
Reel/Frame 049088/0950
Security Interest
Recorded: 2019-05-06
Pages: 7
Assignor
CLOVIS ONCOLOGY, INC.
Executed: 2019-05-01
Assignee
TOP IV SPV GP, LLC
2100 MCKINNEY AVENUE, SUITE 1030, DALLAS, TEXAS, 75201
Covered Properties
(4)
High Dosage Strength Tablets of Rucaparib
Use of PARP Inhibitors to Treat Breast or Ovarian Cancer Patients Showing a Loss of Heterozygosity
Application:
15/104,684 →
Publication:
US 2018/0163271
High Dosage Strength Tablets of Rucaparib
High Dosage Strength Tablets of Rucaparib
Application:
16/154,038 →
Publication:
US 2019/0099430
Related Assignments
(6)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest
Aug 19, 2015
From: ETTER, JEFFREY
To: CLOVIS ONCOLOGY, INC.
Reel/Frame 036362/0974 →
Assignment of Assignor's Interest
Jun 15, 2016
From: LIN, KEVIN
To: CLOVIS ONCOLOGY, INC.
Reel/Frame 038920/0415 →
Assignment of Assignor's Interest
Mar 14, 2018
From: ETTER, JEFFREY
To: CLOVIS ONCOLOGY, INC.
Reel/Frame 045202/0602 →
Assignment of Assignor's Interest
Oct 8, 2018
From: ETTER, JEFFREY
To: CLOVIS ONCOLOGY, INC.
Reel/Frame 047092/0903 →
Patent Security Agreement
Jan 7, 2023
From: CLOVIS ONCOLOGY, INC.
To: TOP IV TALENTS, LLC, AS ADMINISTRATIVE AGENT
Reel/Frame 062319/0943 →
Assignment of Assignor's Interest
May 26, 2023
From: CLOVIS ONCOLOGY, INC.
To: PHARMA& SCHWEIZ GMBH
Reel/Frame 063773/0353 →